About the Program

The 66th Annual Meeting, 2024

In-person or virtual live streaming format is available.
Register for in-person or virtual attendance.

The prevalence of fibrosis is increasing, in part caused by an aging population, advances in diagnostic tools and exposure to infectious agents and other environmental factors that impact pathogenesis. Understanding the effect of these factors on the clinical manifestation of different fibrosis pathologies and pursing novel advances in lung regeneration after scarring will have a significant impact on lung health. The 2024 Thomas L. Petty Aspen Lung Conference will focus on the future of lung fibrosis by integrating clinical unmet needs with the biology of lung fibrosis and fibrosis resolution.

To address this goal, the conference will integrate basic, translational, and clinical approaches to:

1. Understand the common threads of usual interstitial pneumonias (UIPs).
2. Explore the dynamic cellular and structural biology associated with lung fibrosis. 
3. Consider novel approaches to the diagnosis of early lung fibrosis and disease progression.
4. Integrate advances in genetic discoveries to drive basic, translational and clinical research.
5. Discuss transformational interventions for treatment of early and established lung fibrosis.  

The conference will provide an international forum that brings together leading basic, translational, and clinical researchers and welcomes trainees across the fields of pulmonary medicine, genetics, cell biology and immunology with the goal of identifying shared interests that will lead to more productive research and ultimately improve lung health.

Finally, the varied scientific themes and therapeutic strategies that emerge during the conference will be reconciled in the Conference Summary presented by Dr. Patricia Sime (Virginia Commonwealth University). 

Four Fellow Travel Awards will be awarded to fellows whose abstracts have been accepted for podium presentations.